Neurobiological Technologies, Inc. Stock Other OTC
Equities
NTII
US64124W3043
Pharmaceuticals
Sales 2008 | 14.76M 20.19M | Sales 2009 | 26.35M 36.04M | Capitalization | 18.18M 24.86M |
---|---|---|---|---|---|
Net income 2008 | -16M -21.88M | Net income 2009 | 3M 4.1M | EV / Sales 2008 | 0.56 x |
Net cash position 2008 | 29.98M 41M | Net cash position 2009 | 24.05M 32.89M | EV / Sales 2009 | -0.22 x |
P/E ratio 2008 |
-1.69
x | P/E ratio 2009 |
5.82
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |